# Anika Gupta

> Anika Gupta is a Series A investor at Google Ventures backing Therapeutics and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Google Ventures](https://shizune.co/investors/profile/google-ventures)
- Location: Cambridge, United States
- Total investments: 4
- Last investment: Jan 2026
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/anika18
- Website: https://x.com/anikagupta18

Anika Gupta is a Principal at GV, a Harvard Bioinformatics PhD Candidate at Broad Institute of MIT and Harvard, and a Biotech Correspondent at Timmerman Report. He was a Co-founder and Co-president at MIT Biotech Group.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 50% |
| Biotechnology | 2 | 50% |
| Medical | 1 | 25% |
| Health Care | 1 | 25% |
| Pharmaceutical | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EpiBiologics | EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology. | $107M | Series B | Jan 08, 2026 |  |
| EpiBiologics | EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology. | $23M | Series A | Jul 20, 2023 |  |
| EpiBiologics | EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology. | $73.1M | Series A | Mar 22, 2023 |  |
| Pretzel Therapeutics | Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinatingfeatures that make it unlike any other organelle in the body. | $72.5M | Series A | Sep 12, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Mubadala Capital Ventures](https://shizune.co/investors/profile/mubadala-ventures) — VC Fund, 4 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 3 deals together
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 3 deals together
- [Vivo Capital](https://shizune.co/investors/profile/vivo-capital) — VC Fund, 3 deals together
- [Codon Capital](https://shizune.co/investors/profile/codon-capital) — VC Fund, 2 deals together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 2 deals together

## About Google Ventures

VC Fund · Mountain View, United States

Google Ventures invests in sectors including life sciences, consumer, enterprise, crypto, climate, and frontier technology. With Alphabet as its sole limited partner, Google Ventures focuses on long-term investments. Its operating partners assist startups in design, equity, diversity & inclusion, talent, and engineering and help them connectwith Google for technology and expertise. Founded in 2009 as Google Ventures, Google Ventures manages over $8 billion in assets with 400 active portfolio companies in North America and Europe. Some notable investments include Uber, Nest, Slack, GitLab, and One Medical. Google Ventures is based in the San Francisco Bay Area with offices in Cambridge, New York, and London.

5 contacts available at Google Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Andy Wheeler | Partner | https://shizune.co/investors/profile/andy-wheeler |
| Anika Gupta | Principal | https://shizune.co/investors/profile/anika-gupta-b105 |
| Anthony Philippakis | Venture Partner | https://shizune.co/investors/profile/anthony-philippakis |
| Ben Robbins | General Partner | https://shizune.co/investors/profile/ben-robbins |
| Bethany Tsui | Principal and Investor | https://shizune.co/investors/profile/bethany-tsui |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Anika Gupta invest in?

Anika Gupta invests primarily in Therapeutics, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Anika Gupta last invest?

The most recent investment recorded for Anika Gupta closed in Jan 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co